Related Experiment Videos
Uterine rupture during second-trimester abortion associated with misoprostol
L Berghahn1, D Christensen, S Droste
1Department of Obstetrics and Gynecology, University of Wisconsin, Madison, Wisconsin 53792, USA. ljberghahn@hosp.wisc.edu
Obstetrics and Gynecology
|November 13, 2001
Summary
Misoprostol is not recommended for women with a uterine scar, especially in the second trimester. A case study shows uterine rupture can occur, highlighting risks for pregnant patients with prior cesarean sections.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Reproductive Health
Background:
- Misoprostol is contraindicated in term pregnancies with a history of uterine scarring.
- Limited data exist on mid-trimester misoprostol use in women with uterine scars.
Observation:
- A 23-year-old woman with two prior cesarean sections underwent pregnancy termination at 23 weeks' gestation.
- She received misoprostol intravaginally and buccally prior to dilation and evacuation.
- Uterine rupture was diagnosed during the procedure.
Findings:
- The patient experienced uterine rupture following misoprostol administration in the second trimester.
- This event occurred in a patient with a history of uterine scarring (two prior cesarean sections).
Implications:
- Clinicians should exercise extreme caution when considering misoprostol for second-trimester pregnancy termination in women with uterine scars.
- This case underscores the potential for severe complications like uterine rupture.
- Further research is needed to establish safety profiles for misoprostol in specific high-risk obstetric populations.